Table 2:
All patients (N = 39) | Vasoplegia (N = 15) | No vasoplegia (N = 24) | P-value* | |
---|---|---|---|---|
von Willebrand Factor (nM) | 45.6 (32.1–64.1) | 47.5 (36.9–57.3) | 43.1 (25.6–66.4) | 0.77 |
von Willebrand Factor propeptide (nM) | 10.1 (7.2–24.5) | 25.3 (14.9–48.4) | 8.4 (6.6–11.1) | <0.001 |
Osteoprotegerin (pg/ml) | 36.2 (19.1–53.5) | 26.3 (15.5–46.0) | 38.9 (24.6–60.1) | 0.09 |
Angiopoeitin-2 (ng/ml) | 2.4 (2.1–3.1) | 2.5 (2.1–3.5) | 2.4 (2.1–2.8) | 0.57 |
Interleukin-8 (pg/ml) | 8.4 (3.5–13.9) | 8.3 (5.6–17.0) | 8.4 (2.9–13.3) | 0.45 |
Soluble P-selectin (ng/ml) | 62.7 (49.0–76.4) | 76.0 (62.1–81.6) | 54.0 (43.8–72.7) | 0.006 |
Medians and IQRs are shown.
*P-values are given for the comparisons of patients with and without vasoplegia after mitral valve surgery.